Uncategorized
calendar_month Aug 19, 2026

Johnson & Johnson Expands Robotic Bronchoscopy Push With AI, 3D Navigation Upgrade

Johnson & Johnson (NYSE:JNJ) on Monday secured U.S. 510(k) regulatory clearance for MONARCH QUEST 3, the newest software iteration for its robotically-assisted bronchoscopy platform.

The update focuses on improving clinical confidence during complex airway procedures and marks the fourth launch for the MONARCH system in the past 18 months, demonstrating a clear push for continuous medical innovation.

Advances Robotic Bronchoscopy

The MONARCH system operates as the first flexible, robotically-assisted platform designed to help physicians visualize and access patient airways for diagnostic and therapeutic procedures.

With the QUEST 3 update, the healthcare company addresses anatomical changes and CT-to-body divergence that frequently happen during clinical interventions, giving physicians precise control and stable reach.

AI And Imaging Upgrades

The software release introduces AI-powered nodule segmentation, allowing clinicians to automatically generate accurate nodule boundaries with a single click before a procedure begins.

It also deploys software enhancements to improve navigation accuracy as a patient’s anatomy shifts.

Additionally, a new 3D Compass overlay simplifies scope-tip orientation by aligning joystick movements with patient anatomy. The software also expands compatibility with mobile and fixed cone-beam computed tomography (CBCT) imaging systems, enabling medical facilities to use current imaging infrastructure to better target lung nodules.

Integrating Digital Ecosystems

MONARCH QUEST 3 incorporates Polyphonic, the open digital ecosystem developed by Johnson & Johnson. The integration extends surgical intelligence beyond the operating room.

Clinicians can review procedural volume data and collaborate with colleagues through a centralized video library.

Polyphonic organizes each case into a consistent format, making it easier for medical teams to revisit key moments and support ongoing learning.

Price Action

JNJ Stock Price Activity: Johnson & Johnson shares were up 0.58% at $272.68 at the time of publication on Wednesday, according to Benzinga Pro data.

Image via Shutterstock